Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Serologicals Corp (SERO) -- Ignore unavailable to you. Want to Upgrade?

To: John Ritter who wrote (10)	4/18/1999 6:08:00 AM
From: dragonpawn	Read Replies (1) \| Respond to of 23

The following is a copy from YAHO board for your reference: Kussava/Program trading. by: securities_PI (50/M) 197 of 202 I spoke to my broker at Merrill Lynch late Friday afternoon and he told me that program trading is what caused this massive price decline. Most institutions put their holdings on a trading program where certain price targets automatically trigger a sale when hit. When a stock like SERO, or any other for that matter, starts to fall because of an earnings warning, the decline is exacerbated by program trading hitting stop losses on the way down. As more and more stop losses get hit, the decline becomes more pronounced. This is what happened to SERO on Friday. My broker says he is comfortable recommending the stock to his clients, as he believes the stock suffered from overkill. Their analyst who covers this sector says the company is sound and will rebound later in the year. He says that SERO could easily return to double digits by Q4. Hope it will help you make some money by taking the chance to load up SERO at this low price.